Hisashi Arase

No ORCID on file · 4 papers in corpus
2024
Low-dose aspirin and heparin treatment improves pregnancy outcome in recurrent pregnancy loss women with anti-β2-glycoprotein I/HLA-DR autoantibodies: a prospective, multicenter, observational study.
Frontiers in immunology ·doi:10.3389/fimmu.2024.1445852

IntroductionAnti-β2-glycoprotein I (β2GPI)/human leukocyte antigen (HLA)-DR antibodies may be a risk factor for recurrent pregnancy loss (RPL). The therapeutic modality for women with RPL and anti-β2GPI/HLA-DR antibody positivity has not be…

2023
Anti-β2-glycoprotein I/HLA-DR Antibody and Adverse Obstetric Outcomes.
International journal of molecular sciences ·doi:10.3390/ijms241310958

Anti-β2-glycoprotein I/HLA-DR (anti-β2GPI/HLA-DR) antibody has been reported to be associated with antiphospholipid syndrome and recurrent pregnancy loss (RPL). We conducted a prospective multicenter cross-sectional study aimed at evaluatin…

article 2023
Anti-β2-glycoprotein I/HLA-DR antibody in infertility
Journal of reproductive immunology ·doi:10.1016/j.jri.2023.103955

To evaluate whether anti-β2-Glycoprotein I/HLA-DR (anti-β2GPI/HLA-DR) antibody is associated with pathophysiology of infertility, 224 women with infertility were enrolled from July 2020 to December 2021 in this prospective study. The serum …

2021
Acquisition of resistance to wild-type spike-immune sera by emerging SARS-CoV-2 variants
·doi:10.21203/rs.3.rs-963907/v1

Abstract Breakthrough infection is often observed for the SARS-CoV-2 Delta variant, and neutralizing antibody levels are associated with vaccine efficiency1. Recent studies revealed that not only anti-receptor binding domain (RBD) antibodi…